Alkaç, I. M. Et Al. 2022. Investigation of Sensitivity to AZD7762 in TripleNegative Breast Cancer (TNBC) with RBFOX2 Gene Expression as a Biomarker. EXPERIMED , vol.12, no.2 , 33-37.

Alkaç, I. M., Işbilen, M., Küçükkaraduman, B., Güre, A. O., & Vural, B., (2022). Investigation of Sensitivity to AZD7762 in TripleNegative Breast Cancer (TNBC) with RBFOX2 Gene Expression as a Biomarker. EXPERIMED , vol.12, no.2, 33-37.

Alkaç, Ismal Et Al. "Investigation of Sensitivity to AZD7762 in TripleNegative Breast Cancer (TNBC) with RBFOX2 Gene Expression as a Biomarker," EXPERIMED , vol.12, no.2, 33-37, 2022

Alkaç, Ismal M. Et Al. "Investigation of Sensitivity to AZD7762 in TripleNegative Breast Cancer (TNBC) with RBFOX2 Gene Expression as a Biomarker." EXPERIMED , vol.12, no.2, pp.33-37, 2022

Alkaç, I. M. Et Al. (2022) . "Investigation of Sensitivity to AZD7762 in TripleNegative Breast Cancer (TNBC) with RBFOX2 Gene Expression as a Biomarker." EXPERIMED , vol.12, no.2, pp.33-37.

@article{article, author={Ismal Mert Alkaç Et Al. }, title={Investigation of Sensitivity to AZD7762 in TripleNegative Breast Cancer (TNBC) with RBFOX2 Gene Expression as a Biomarker}, journal={EXPERIMED}, year=2022, pages={33-37} }